RecruitingACTRN12616001453471

Funded pharmacy vaccination of pregnant women: uptake and views and experiences

Funded pharmacist-delivered pertussis and influenza vaccination of pregnant women. The effect on vaccine uptake and views and experiences of women and health professionals


Sponsor

Dr Natalie Gauld

Enrollment

27,000 participants

Start Date

Apr 13, 2018

Study Type

Observational

Conditions

Summary

Low uptake of influenza vaccine and pertussis vaccine in pregnancy in New Zealand needs to be addressed. The hypothesis we seek to test is that providing funded pertussis and influenza vaccinations in pregnancy through community pharmacy will increase uptake in pregnant women, including those living in areas of higher household deprivation, and in women of Maori ethnicity. In one area of NZ (intervention area) these vaccinations will be funded through community pharmacies as well as the traditional areas (general practice and hospitals). In geographically comparable areas (controls) funding remains standard (general practice and hospital). The study will measure uptake overall and by location of vaccine delivery in women, and a further analysis will examine uptake in Maori and high deprivation populations,


Eligibility

Sex: Females

Plain Language Summary

Simplified for easier understanding

This study is looking at whether making influenza and whooping cough (pertussis) vaccines available at community pharmacies — instead of just at doctor's offices and hospitals — increases the number of pregnant women who get vaccinated. The study is being run in selected areas of New Zealand and focuses on whether easier access improves uptake, especially among Maori women and those living in lower-income areas. You may be eligible if: - You were pregnant during the study period - You are a New Zealand resident - You were eligible for funded vaccines during your pregnancy - Your baby survived beyond 27 weeks of pregnancy You may NOT be eligible if: - Your baby was born before 27 weeks - You did not deliver a live baby - You are not eligible for funded vaccines (e.g., not a NZ resident) Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Influenza vaccine was funded in pregnancy in pharmacy nationally, ie in all areas as from 1 April 2017. and Waikato started from Nov 2016 funding pertussis. This will now be called an observational st

Influenza vaccine was funded in pregnancy in pharmacy nationally, ie in all areas as from 1 April 2017. and Waikato started from Nov 2016 funding pertussis. This will now be called an observational study. Drugs and dose: Combined diphtheria-tetanus-acellular pertussis vaccine (funded for a single delivery between week 28 and week 38 of pregnancy) and influenza vaccine (funded for a single delivery at any stage of pregnancy), both vaccines will be delivered by intra-muscular injection. The period observed will be 24 months. Any pregnant woman in the Waikato will be able to present to a pharmacy (or traditional areas ie general practice or hospitals) for the funded vaccinations.


Locations(1)

New Zealand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12616001453471


Related Trials